BASi shares soar as it joins operations with CRO Seventh Wave Labs

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/scyther5)
(Image: Getty/scyther5)

Related tags: CRO, Basi, Laboratory

BASi and Seventh Wave Laboratories are joining operations via an asset purchase agreement, through which BASi will lease the CRO's facility in Maryland Heights, MO.

Following news of its asset purchase deal with Seventh Wave Laboratories – a consulting-based contract research organization (CRO) – Bioanalytical Systems (BASi) shares​ were up approximately 34%.

As per the asset purchase agreement (APA), Maryland Heights, MO-based Seventh Wave Laboratories received 1,500,000 Common Shares of BASi and approximately $7m in cash in exchange for its assets.

“We are all excited to have the APA complete and begin the integration process,”​ said Jill Blumhoff, CFO of BASi, a CRO based West Lafayette, IN. “We believe that our service offerings complement each other well and that we can leverage the scientific expertise of each company to achieve future growth.”

According to the SEC filing​, BASi will lease “certain premises” in Maryland Heights, MO owned by SWL Properties LLC, an entity controlled by certain members of Seventh Wave Laboratories, including John Sagartz, Seventh Wave Laboratories’ president and CEO – who has joined the BASi Board of Directors as of today.

Under the lease arrangements, BASi has agreed to lease the premises for approximately seven years. The agreement will automatically extend for an additional two seven-year terms unless terminated.

Annual rent ranges from $390,000 for the first year to $440,987 for the seventh year, according to the filing.

Related topics: Preclinical Research

Related news

Follow us

Products

View more

Webinars